Skip to main content
. 2004 Jan 26;2004(1):CD002848. doi: 10.1002/14651858.CD002848.pub2

Escobar 1988.

Methods Randomization: no details
Allocation concealment: no details
Blinding: double (vaccine and placebo were identical)
Data collection: no details
Intention to treat: no information
Interim analysis: no information
Exclusion from analysis: no information
Follow‐up period: 3 weeks after vaccination
Participants Age: 6 to 18 months
Health status: without diarrhoea, no further details
Breastfeeding: no information
Immunization status: no information
Interventions 1. Bovine RIT 4237, 0.5 ml, 10^8 DICT 50, single dose (n = 52)
2. Placebo (same preparation without the virus), single dose (n = 51)
110 ml of formula given before vaccine or placebo
Outcomes 1. Efficacy: rotavirus diarrhoea within 3 weeks of vaccination
Notes Study location: Spain
Clinical symptoms: clinical evaluation, no further details
Laboratory studies: serology and stool analysis by ELISA